Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2007
08/02/2007US20070179158 2,6-Disubstituted piperiddines as modulators
08/02/2007US20070179156 3-(isoquinolin-1-ylamino)-5-(6-(methylamino)pyrazin-2-yl)pyridin-2(1H)-one; autoimmune, inflammatory, proliferative, or hyperproliferative disease or an immunologically-mediated disease
08/02/2007US20070179150 Nitrosated proton pump inhibitors, compositions and methods of use
08/02/2007US20070179146 2-{4-[3-(3,4-dimethoxy-phenyl)-5.5-dimethyl-6-oxa-5,6-dihydro-4H-pyridazin-1-yl]-piperidine-1-sulfonyl}-benzonitrile; low toxicity, high bioavailability, side effects reduction; antiinflammatory agents; antiallergenic; respiratory disorders
08/02/2007US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
08/02/2007US20070179141 Therapeutic agents useful for treating pain
08/02/2007US20070179132 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
08/02/2007US20070179127 Sulfonamide compound
08/02/2007US20070179060 6-(Poly-substituted aryl)-4-aminopicolinates and their use as herbicides
08/02/2007CA2637933A1 Indole sulfonamide modulators of progesterone receptors
08/02/2007CA2637312A1 Use of substituted 2-imidazole of imidazoline derivatives
08/02/2007CA2637261A1 Use of 2-imidazoles for the treatment of cns disorders
08/02/2007CA2636931A1 Piperazines and piperidines as mglur5 potentiators
08/02/2007CA2635439A1 Aminophthalazine derivative compounds
08/02/2007CA2627607A1 Fap inhibitors
08/01/2007EP1813651A1 Optical filter
08/01/2007EP1813610A1 Novel pyridonecarboxylic acid derivatives or salts thereof
08/01/2007EP1813609A2 Novel aminopyridine derivatives having selective aurora-a inhibitory effect
08/01/2007EP1813603A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both
08/01/2007EP1812421A2 Anthranilamide insecticides
08/01/2007EP1812410A2 Indinavir derivatives useful in immunoassay
08/01/2007EP1812408A2 Pyridazine compounds, compositions and methods
08/01/2007EP1812406A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
08/01/2007EP1812405A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs
08/01/2007EP1812400A1 Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
08/01/2007EP1812398A1 Compounds having activity at nk3 receptor and uses thereof in medicine
08/01/2007EP1812388A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease
08/01/2007EP1812112A2 Chemical compounds
08/01/2007EP1811998A1 Triazoles useful as inhibitors of protein kinases
08/01/2007EP1811993A2 Modulators of crth2, cox-2 and faah
08/01/2007EP1811845A2 Substituted biaryl quinolin-4-ylamine analogues
08/01/2007EP1706397A4 Novel amorphous form of omeprazole salts
08/01/2007EP1581505B1 Pyridazinone derivatives as gsk-3beta inhibitors
08/01/2007EP1565456A4 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
08/01/2007EP1560811B1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
08/01/2007EP1546130B1 Piperidine derivatives for use in the treatment of chemokine mediated disease states
08/01/2007EP1507760B1 Cyanoguanidine prodrugs
08/01/2007EP1487822B1 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors
08/01/2007EP1484327B1 Nitrogenous heterocyclic compound and medicine thereof
08/01/2007EP1373194B1 BENZAMIDE INHIBITORS OF FACTOR Xa
08/01/2007EP1355904B1 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
08/01/2007EP1294698B1 Fused azepine derivatives and their use as antidiuretic agents
08/01/2007EP1289929B1 Shortened synthesis of 3,3-diarylpropylamine derivatives
08/01/2007EP1187592B1 Alpha v integrin receptor antagonists
08/01/2007EP1018879B1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
08/01/2007CN1329389C Novel compounds and their use
08/01/2007CN1329388C 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors
08/01/2007CN1329382C Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders
08/01/2007CN1329378C Compounds useful to treat retroviral infections
08/01/2007CN1329375C Novel anti-diabetic agents
08/01/2007CN1329374C Compound as CCR5 agonist
08/01/2007CN101010317A 2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
08/01/2007CN101010316A Compounds useful for inhibiting CHK1
08/01/2007CN101010315A Substituted pyrazolyl urea derivatives useful in the treatment of cancer
08/01/2007CN101010314A Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
08/01/2007CN101010313A Derivatives of indol-2-one for treating neurological disorders, gastrointestinal disorders and cardiovascular disorder
08/01/2007CN101010302A Sigma receptor inhibitors
08/01/2007CN101010301A 5-HT7 receptor antagonosts
08/01/2007CN101010299A Six-membered heterocycles useful as serine protease inhibitors
08/01/2007CN101010296A Piperazine derivatives of alkyhydroxy indole
08/01/2007CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
08/01/2007CN101007802A Mediators of hedgehog signaling pathways, compositions and uses related thereto
08/01/2007CN101007800A Compound for preparing nifeviroc and its preparing process
08/01/2007CN101007799A Pyrimidine salicylic acid cluster molecule with herbicide activity
08/01/2007CN101007784A Antibacterial agents
07/2007
07/31/2007USRE39754 Benzamide derivatives and pharmaceutical compositions containing same
07/31/2007US7250518 treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic bronchitis, and chronic obstructuive pulmonary disease
07/31/2007US7250516 Phenylalanine derivatives
07/31/2007US7250513 Heating to isomerize
07/31/2007US7250512 An iridium complex of 2-(2-thienyl)-5-trifluoromethyl)pyridine compounds; light-emitting diodes
07/31/2007US7250444 Pyrrole-based HMG-CoA reductase inhibitors
07/31/2007US7250443 Pyrrole based inhibitors of glycogen synthase kinase 3
07/31/2007US7250442 glucocorticoid, androgen, mineralcorticoid, estrogen and progesterone receptor modulators such as 3,3-Bis-(4-hydroxy-3,5-dimethyl-phenyl)-1-(4-methoxy-benzyl)-1,3-dihydro-indol-2-one, used for treating congestive heart failure
07/31/2007US7250437 Pyrrazoles connnected to a carbocyclic ring by a vinylene, butadienylene or hexatrienylene bridge, e.g. 3(5)-[2-(2-chloro-5-trifluoromethylphenyl)vinyl]-1H-pyrazole; compounds exhibit antifibrotic and antiapoptotic activities
07/31/2007US7250435 5-(Thio)Carbonylamino-indeno[1,2-c]pyrazol-4-ones, e.g., 3-(4-methoxyphenyl)-5-(2-phenethylacetylhydrazine carboxamido)indeno[1,2-c]pyrazol-4-one and 3-(4-methoxyphenyl)-5-(2-methoxycarbonyl hydrazinecarboxamido)indeno[1,2-c]pyrazol-4-one
07/31/2007US7250434 Diarylimidazoles, substituted with another aromatic ring and one or more carboxylic acids, esters or amides, e.g., 3-[5-Benzo[1,3]dioxol-5-yl-4-(2,5-dichloro-phenyl)-1H-imidazol-2-yl]-2-(3-chloro-phenyl)-acrylic acid; treatment of conditions such as pain, drug dependence, and psychological disorders
07/31/2007US7250424 Fab I inhibitors
07/31/2007US7250421 Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase
07/31/2007US7250418 Corticotropin releasing factor antagonist; antiinflammatory agents; drug abuse; analgesics; antihistamines; skin disorders; neurodegenerative disease; eating disorders;eating disorders; antiepileptic agents; cardiovascular disorders
07/31/2007US7250410 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
07/31/2007CA2398353C Anticancer compound and enantiomer separation method useful for synthesizing said compound
07/31/2007CA2305612C Halogen substituted tetracyclic tetrahydrofuran derivatives
07/31/2007CA2275306C Novel tetrahydrobenzindolone derivatives
07/31/2007CA2175212C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
07/31/2007CA2121253C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
07/26/2007WO2007084875A2 Spiro compounds and methods of use
07/26/2007WO2007084786A1 Pyrimidine derivatives used as pi-3 kinase inhibitors
07/26/2007WO2007084532A2 Combination therapy with parp inhibitors
07/26/2007WO2007084498A1 Piperazine derivatives as farnesyl protein transferase inhibitors
07/26/2007WO2007084435A2 Methods for treating hepatitis c
07/26/2007WO2007084413A2 Methods for treating hepatitis c
07/26/2007WO2007083732A1 Optical recording medium and azo metal chelate compound
07/26/2007WO2007083207A1 Substituted imidazoles and their use as pesticides
07/26/2007WO2007083089A1 Chemical compounds
07/26/2007WO2007083036A1 Novel lanthanide ligands and complexes, and use thereof as contrast agents
07/26/2007WO2007082882A1 Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
07/26/2007WO2007082878A1 Aminophenyl derivatives as novel inhibitors of histone deacetylase
07/26/2007WO2007082873A1 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
07/26/2007WO2007082805A1 Cis-4, 5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors
07/26/2007WO2007082666A1 Acylaminoimidazoles